
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-a68b4900.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-0a3f24ce.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Assessment of Long‐Term Use Versus Discontinuation of Direct Oral Anticoagulant After Catheter Ablation for Atrial Fibrillation—RYOUMA Registry Subanalysis - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="68F7E0628095406300E0620027870E57.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="annnoninvas">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11966009/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Annals of Noninvasive Electrocardiology">
<meta name="citation_title" content="Assessment of Long‐Term Use Versus Discontinuation of Direct Oral Anticoagulant After Catheter Ablation for Atrial Fibrillation—RYOUMA Registry Subanalysis">
<meta name="citation_author" content="Yuka Oda">
<meta name="citation_author_institution" content="Department of Cardiology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan">
<meta name="citation_author" content="Akihiko Nogami">
<meta name="citation_author_institution" content="Department of Cardiology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan">
<meta name="citation_author_institution" content="Department of Cardiology, Tokyo Heart Rhythm Hospital, Tokyo, Japan">
<meta name="citation_author" content="Yuki Komatsu">
<meta name="citation_author_institution" content="Department of Cardiology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan">
<meta name="citation_author" content="Kyoko Soejima">
<meta name="citation_author_institution" content="Department of Cardiology, Kyorin University School of Medicine, Tokyo, Japan">
<meta name="citation_author" content="Itsuro Morishima">
<meta name="citation_author_institution" content="Department of Cardiology, Ogaki Municipal Hospital, Ogaki, Japan">
<meta name="citation_author" content="Kenichi Hiroshima">
<meta name="citation_author_institution" content="Cardiovascular Division, Kokura Memorial Hospital, Fukuoka, Japan">
<meta name="citation_author" content="Ritsushi Kato">
<meta name="citation_author_institution" content="Department of Arrhythmia, Saitama Medical University International Medical Center, Saitama, Japan">
<meta name="citation_author" content="Satoru Sakagami">
<meta name="citation_author_institution" content="Department of Cardiology, National Hospital Organization Kanazawa Medical Center, Kanazawa, Ishikawa, Japan">
<meta name="citation_author" content="Fumiharu Miura">
<meta name="citation_author_institution" content="Department of Cardiovascular Medicine, Hiroshima Prefectural Hospital, Hiroshima, Japan">
<meta name="citation_author" content="Keisuke Okawa">
<meta name="citation_author_institution" content="Department of Cardiovascular Medicine, Kagawa Prefectural Central Hospital, Takamatsu, Kagawa, Japan">
<meta name="citation_author" content="Masayuki Fukuzawa">
<meta name="citation_author_institution" content="Primary Medical Science Department, DAIICHI SANKYO co., Ltd. Tokyo, Japan">
<meta name="citation_author" content="Atsushi Takita">
<meta name="citation_author_institution" content="Data Intelligence Department, DAIICHI SANKYO co., Ltd. Tokyo, Japan">
<meta name="citation_author" content="Kikuya Uno">
<meta name="citation_author_institution" content="Department of Cardiology, Tokyo Heart Rhythm Hospital, Tokyo, Japan">
<meta name="citation_author" content="Koichiro Kumagai">
<meta name="citation_author_institution" content="Heart Rhythm Center, Fukuoka Sanno Hospital, Fukuoka, Japan">
<meta name="citation_author" content="Takashi Kurita">
<meta name="citation_author_institution" content="Division of Cardiovascular Center, Kindai University School of Medicine, Osaka, Japan">
<meta name="citation_author" content="Masahiko Gosho">
<meta name="citation_author_institution" content="Department of Biostatistics, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan">
<meta name="citation_author" content="Tomoko Ishizu">
<meta name="citation_author_institution" content="Department of Cardiology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan">
<meta name="citation_author" content="Kazutaka Aonuma">
<meta name="citation_author_institution" content="Department of Cardiology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan">
<meta name="citation_author" content="the RYOUMA Investigators">
<meta name="citation_publication_date" content="2025 Apr 3">
<meta name="citation_volume" content="30">
<meta name="citation_issue" content="3">
<meta name="citation_firstpage" content="e70067">
<meta name="citation_doi" content="10.1111/anec.70067">
<meta name="citation_pmid" content="40176712">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC11966009/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC11966009/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC11966009/pdf/ANEC-30-e70067.pdf">
<meta name="description" content="The relationship between oral anticoagulant (OAC) status after catheter ablation (CA) for atrial fibrillation (AF) and the risks of ischemic stroke or major bleeding events is still unknown. This is a subanalysis of the RYOUMA registry, a ...">
<meta name="og:title" content="Assessment of Long‐Term Use Versus Discontinuation of Direct Oral Anticoagulant After Catheter Ablation for Atrial Fibrillation—RYOUMA Registry Subanalysis">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="The relationship between oral anticoagulant (OAC) status after catheter ablation (CA) for atrial fibrillation (AF) and the risks of ischemic stroke or major bleeding events is still unknown. This is a subanalysis of the RYOUMA registry, a ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC11966009/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-testid="header" data-header >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            
                <a class="ncbi-header__logo-container" href="https://www.ncbi.nlm.nih.gov/">
                    <img alt="
                                  NCBI home page
                              "
                         class="ncbi-header__logo-image"
                         src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg" />
                </a>
            

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-testid="searchPanel"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      aria-describedby="search-field-desktop-navigation-help-text"
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only"
                           data-testid="label"
                           for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           data-testid="textInput"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    data-testid="button"
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  role="search">
                <label class="usa-sr-only" for="search-field">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="search" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        <a class="usa-link" href="https://www.ncbi.nlm.nih.gov/pmc/advanced/" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="11966009">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1111/anec.70067"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/ANEC-30-e70067.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC11966009%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/11966009/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/11966009/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC11966009/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-annoninvas.jpg" alt="Annals of Noninvasive Electrocardiology logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Annals of Noninvasive Electrocardiology" title="Link to Annals of Noninvasive Electrocardiology" shape="default" href="https://onlinelibrary.wiley.com/journal/1542474x" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Ann Noninvasive Electrocardiol</button></div>. 2025 Apr 3;30(3):e70067. doi: <a href="https://doi.org/10.1111/anec.70067" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1111/anec.70067</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Ann%20Noninvasive%20Electrocardiol%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ann%20Noninvasive%20Electrocardiol%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Ann%20Noninvasive%20Electrocardiol%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Ann%20Noninvasive%20Electrocardiol%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Assessment of Long‐Term Use Versus Discontinuation of Direct Oral Anticoagulant After Catheter Ablation for Atrial Fibrillation—RYOUMA Registry Subanalysis</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Oda%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Yuka Oda</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Yuka Oda</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Department of Cardiology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Oda%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yuka Oda</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nogami%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Akihiko Nogami</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Akihiko Nogami</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Department of Cardiology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan</div>
<div class="p">
<sup>
<sup>2</sup>
</sup>Department of Cardiology, Tokyo Heart Rhythm Hospital, Tokyo, Japan</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nogami%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Akihiko Nogami</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Komatsu%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Yuki Komatsu</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Yuki Komatsu</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Department of Cardiology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Komatsu%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yuki Komatsu</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Soejima%20K%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Kyoko Soejima</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Kyoko Soejima</span></h3>
<div class="p">
<sup>
<sup>3</sup>
</sup>Department of Cardiology, Kyorin University School of Medicine, Tokyo, Japan</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Soejima%20K%22%5BAuthor%5D" class="usa-link"><span class="name western">Kyoko Soejima</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Morishima%20I%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Itsuro Morishima</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Itsuro Morishima</span></h3>
<div class="p">
<sup>
<sup>4</sup>
</sup>Department of Cardiology, Ogaki Municipal Hospital, Ogaki, Japan</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Morishima%20I%22%5BAuthor%5D" class="usa-link"><span class="name western">Itsuro Morishima</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hiroshima%20K%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Kenichi Hiroshima</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Kenichi Hiroshima</span></h3>
<div class="p">
<sup>
<sup>5</sup>
</sup>Cardiovascular Division, Kokura Memorial Hospital, Fukuoka, Japan</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hiroshima%20K%22%5BAuthor%5D" class="usa-link"><span class="name western">Kenichi Hiroshima</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kato%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Ritsushi Kato</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Ritsushi Kato</span></h3>
<div class="p">
<sup>
<sup>6</sup>
</sup>Department of Arrhythmia, Saitama Medical University International Medical Center, Saitama, Japan</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kato%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Ritsushi Kato</span></a>
</div>
</div>
<sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sakagami%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Satoru Sakagami</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Satoru Sakagami</span></h3>
<div class="p">
<sup>
<sup>7</sup>
</sup>Department of Cardiology, National Hospital Organization Kanazawa Medical Center, Kanazawa, Ishikawa, Japan</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sakagami%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Satoru Sakagami</span></a>
</div>
</div>
<sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Miura%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Fumiharu Miura</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Fumiharu Miura</span></h3>
<div class="p">
<sup>
<sup>8</sup>
</sup>Department of Cardiovascular Medicine, Hiroshima Prefectural Hospital, Hiroshima, Japan</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Miura%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">Fumiharu Miura</span></a>
</div>
</div>
<sup>8</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Okawa%20K%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Keisuke Okawa</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Keisuke Okawa</span></h3>
<div class="p">
<sup>
<sup>9</sup>
</sup>Department of Cardiovascular Medicine, Kagawa Prefectural Central Hospital, Takamatsu, Kagawa, Japan</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Okawa%20K%22%5BAuthor%5D" class="usa-link"><span class="name western">Keisuke Okawa</span></a>
</div>
</div>
<sup>9</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fukuzawa%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Masayuki Fukuzawa</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Masayuki Fukuzawa</span></h3>
<div class="p">
<sup>
<sup>10</sup>
</sup>Primary Medical Science Department, DAIICHI SANKYO co., Ltd. Tokyo, Japan</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fukuzawa%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Masayuki Fukuzawa</span></a>
</div>
</div>
<sup>10</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Takita%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Atsushi Takita</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Atsushi Takita</span></h3>
<div class="p">
<sup>
<sup>11</sup>
</sup>Data Intelligence Department, DAIICHI SANKYO co., Ltd. Tokyo, Japan</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Takita%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Atsushi Takita</span></a>
</div>
</div>
<sup>11</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Uno%20K%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">Kikuya Uno</span></a><div hidden="hidden" id="id13">
<h3><span class="name western">Kikuya Uno</span></h3>
<div class="p">
<sup>
<sup>2</sup>
</sup>Department of Cardiology, Tokyo Heart Rhythm Hospital, Tokyo, Japan</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Uno%20K%22%5BAuthor%5D" class="usa-link"><span class="name western">Kikuya Uno</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kumagai%20K%22%5BAuthor%5D" class="usa-link" aria-describedby="id14"><span class="name western">Koichiro Kumagai</span></a><div hidden="hidden" id="id14">
<h3><span class="name western">Koichiro Kumagai</span></h3>
<div class="p">
<sup>
<sup>12</sup>
</sup>Heart Rhythm Center, Fukuoka Sanno Hospital, Fukuoka, Japan</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kumagai%20K%22%5BAuthor%5D" class="usa-link"><span class="name western">Koichiro Kumagai</span></a>
</div>
</div>
<sup>12</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kurita%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id15"><span class="name western">Takashi Kurita</span></a><div hidden="hidden" id="id15">
<h3><span class="name western">Takashi Kurita</span></h3>
<div class="p">
<sup>
<sup>13</sup>
</sup>Division of Cardiovascular Center, Kindai University School of Medicine, Osaka, Japan</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kurita%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Takashi Kurita</span></a>
</div>
</div>
<sup>13</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gosho%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id16"><span class="name western">Masahiko Gosho</span></a><div hidden="hidden" id="id16">
<h3><span class="name western">Masahiko Gosho</span></h3>
<div class="p">
<sup>
<sup>14</sup>
</sup>Department of Biostatistics, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gosho%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Masahiko Gosho</span></a>
</div>
</div>
<sup>14</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ishizu%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id17"><span class="name western">Tomoko Ishizu</span></a><div hidden="hidden" id="id17">
<h3><span class="name western">Tomoko Ishizu</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Department of Cardiology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ishizu%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Tomoko Ishizu</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Aonuma%20K%22%5BAuthor%5D" class="usa-link" aria-describedby="id18"><span class="name western">Kazutaka Aonuma</span></a><div hidden="hidden" id="id18">
<h3><span class="name western">Kazutaka Aonuma</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Department of Cardiology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Aonuma%20K%22%5BAuthor%5D" class="usa-link"><span class="name western">Kazutaka Aonuma</span></a>
</div>
</div>
<sup>1</sup>; <span class="collab">the RYOUMA Investigators</span>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="anec70067-aff-0001">
<sup>
<sup>1</sup>
</sup>Department of Cardiology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan</div>
<div id="anec70067-aff-0002">
<sup>
<sup>2</sup>
</sup>Department of Cardiology, Tokyo Heart Rhythm Hospital, Tokyo, Japan</div>
<div id="anec70067-aff-0003">
<sup>
<sup>3</sup>
</sup>Department of Cardiology, Kyorin University School of Medicine, Tokyo, Japan</div>
<div id="anec70067-aff-0004">
<sup>
<sup>4</sup>
</sup>Department of Cardiology, Ogaki Municipal Hospital, Ogaki, Japan</div>
<div id="anec70067-aff-0005">
<sup>
<sup>5</sup>
</sup>Cardiovascular Division, Kokura Memorial Hospital, Fukuoka, Japan</div>
<div id="anec70067-aff-0006">
<sup>
<sup>6</sup>
</sup>Department of Arrhythmia, Saitama Medical University International Medical Center, Saitama, Japan</div>
<div id="anec70067-aff-0007">
<sup>
<sup>7</sup>
</sup>Department of Cardiology, National Hospital Organization Kanazawa Medical Center, Kanazawa, Ishikawa, Japan</div>
<div id="anec70067-aff-0008">
<sup>
<sup>8</sup>
</sup>Department of Cardiovascular Medicine, Hiroshima Prefectural Hospital, Hiroshima, Japan</div>
<div id="anec70067-aff-0009">
<sup>
<sup>9</sup>
</sup>Department of Cardiovascular Medicine, Kagawa Prefectural Central Hospital, Takamatsu, Kagawa, Japan</div>
<div id="anec70067-aff-0010">
<sup>
<sup>10</sup>
</sup>Primary Medical Science Department, DAIICHI SANKYO co., Ltd. Tokyo, Japan</div>
<div id="anec70067-aff-0011">
<sup>
<sup>11</sup>
</sup>Data Intelligence Department, DAIICHI SANKYO co., Ltd. Tokyo, Japan</div>
<div id="anec70067-aff-0012">
<sup>
<sup>12</sup>
</sup>Heart Rhythm Center, Fukuoka Sanno Hospital, Fukuoka, Japan</div>
<div id="anec70067-aff-0013">
<sup>
<sup>13</sup>
</sup>Division of Cardiovascular Center, Kindai University School of Medicine, Osaka, Japan</div>
<div id="anec70067-aff-0014">
<sup>
<sup>14</sup>
</sup>Department of Biostatistics, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan</div>
<div class="author-notes p">
<div class="fn" id="correspondenceTo">
<sup>*</sup><p class="display-inline">

<strong>Correspondence:</strong>
 
Akihiko Nogami (<span>akihiko-ind@umin.ac.jp</span>)
</p>
</div>
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Revised 2025 Feb 24; Received 2024 Dec 3; Accepted 2025 Mar 10; Collection date 2025 May.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2025 The Author(s). <em>Annals of Noninvasive Electrocardiology</em> published by Wiley Periodicals LLC.</div>
<p>This is an open access article under the terms of the <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc-nd/4.0/</a> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC11966009  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40176712/" class="usa-link">40176712</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>ABSTRACT</h2>
<section id="anec70067-sec-0001"><h3 class="pmc_sec_title">Background</h3>
<p>The relationship between oral anticoagulant (OAC) status after catheter ablation (CA) for atrial fibrillation (AF) and the risks of ischemic stroke or major bleeding events is still unknown.</p></section><section id="anec70067-sec-0002"><h3 class="pmc_sec_title">Methods</h3>
<p>This is a subanalysis of the RYOUMA registry, a prospective multicenter observational study of Japanese patients who underwent CA for AF in 2017–2018.</p></section><section id="anec70067-sec-0003"><h3 class="pmc_sec_title">Results</h3>
<p>Of the 2844 patients, the rate of DOAC continuation was 48.1%, 69.6%, and 80.9% in patients with a CHADS2 score of 0–1, 2, and 3–6, respectively. Among the patients taking DOACs with a CHADS2 score of 0–1 and 2, the incidence rates of major bleeding were significantly higher than those of ischemic stroke or systemic embolic events (SEEs) (1.3%/year [95% CI, 0.6–2.1] vs. 0.3%/year [95% CI, 0.0–0.7], <em>p</em> = 0.019; 1.8%/year [95% CI, 0.6–3.0] vs. 0.2%/year [95% CI, 0.0–0.6], <em>p</em> = 0.018, respectively). However, there was no difference between the incidence rates of major bleeding events and ischemic stroke or SEEs in patients taking DOACs with a CHADS2 score of 3–6 (1.6%/year [95% CI, 0.2–3.0] vs. 1.0%/year [95% CI, 0.0–2.1], <em>p</em> = 0.474).</p></section><section id="anec70067-sec-0004"><h3 class="pmc_sec_title">Conclusions</h3>
<p>In patients with a CHADS2 score of 2, those who continued taking DOACs had a higher incidence rate of major bleeding events compared to ischemic stroke/SEEs, similar to those with a CHADS2 score of 0–1. Conversely, in patients with a CHADS2 score of 3–6, the incidence rates of both ischemic stroke/SEEs and major bleeding were similarly high.</p>
<p>
<strong>Trial Registration:</strong> The study was registered as UMIN000026092 (University Hospital Medical Information Network‐Clinical Trial Registry)</p></section><section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> anticoagulation, atrial fibrillation, catheter ablation, hemorrhage, stroke</p></section></section><section class="abstract" id="abstract2"><hr class="headless">
<section class="bt xbox font-sm" id="anec70067-blkfxd-0001"><p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c858/11966009/9231a92d602f/ANEC-30-e70067-g003.jpg" loading="lazy" id="jats-graphic-1" height="186" width="332" alt="graphic file with name ANEC-30-e70067-g003.jpg"></p></section></section><section id="anec70067-sec-0005"><h2 class="pmc_sec_title">1. Introduction</h2>
<p>Catheter ablation (CA) is an effective therapeutic strategy for atrial fibrillation (AF) (Tzeis et al. <a href="#anec70067-bib-0012" class="usa-link" aria-describedby="anec70067-bib-0012">2024</a>; Hindricks et al. <a href="#anec70067-bib-0003" class="usa-link" aria-describedby="anec70067-bib-0003"><sup>2021</sup></a>; Nogami et al. <a href="#anec70067-bib-0008" class="usa-link" aria-describedby="anec70067-bib-0008"><sup>2021</sup></a>). Periprocedural oral anticoagulation (OAC) is crucial for preventing periprocedural thromboembolism; nonetheless, the optimal long‐term anticoagulation after successful AF ablation remains controversial. Current guidelines and consensus statements (Tzeis et al. <a href="#anec70067-bib-0012" class="usa-link" aria-describedby="anec70067-bib-0012">2024</a>; Hindricks et al. <a href="#anec70067-bib-0003" class="usa-link" aria-describedby="anec70067-bib-0003"><sup>2021</sup></a>; Nogami et al. <a href="#anec70067-bib-0008" class="usa-link" aria-describedby="anec70067-bib-0008"><sup>2021</sup></a>); however, recommend continuation of OAC based on clinical risk scoring, irrespective of procedural outcome. In Japanese guidelines (Nogami et al. <a href="#anec70067-bib-0008" class="usa-link" aria-describedby="anec70067-bib-0008">2021</a>), continuation of OAC after AF ablation is recommended for all patients for at least 3 months. After 3 months post‐ablation, interruption of OAC should be considered in the patients with a CHADS2 score of 0. Patients with a CHADS2 score of 1 may also be considered for the interruption of OAC, considering the balance between the risk of thromboembolism and bleeding events. On the other hand, for patients with a CHADS2 score of ≥ 2, continuation of OAC beyond 3 months post‐ablation is recommended, considering the risk of ischemic stroke when atrial arrhythmias recur (class IIa). However, our previous report of the RYOUMA registry (Real world ablation therapY with anti‐cOagUlants in Management of Atrial fibrillation) revealed that over half of the patients continued OAC therapy at 1 year after CA, and there are some patients with the continuation of OAC beyond 3 months despite a CHADS2 score of 0 or 1, as well as those with discontinuation of OAC with a CHADS2 score of ≥ 2 (Figure <a href="#anec70067-supitem-0001" class="usa-link">S1</a>) (Nogami et al. <a href="#anec70067-bib-0009" class="usa-link" aria-describedby="anec70067-bib-0009">2022</a>). Therefore, in this subanalysis, we examined the characteristics of patients who either continued or discontinued DOAC therapy after AF ablation in relation to their CHADS2 score. Furthermore, we evaluated the risk of stroke and major bleeding following CA in patients with and without guideline‐recommended anticoagulation therapy.</p></section><section id="anec70067-sec-0006"><h2 class="pmc_sec_title">2. Methods</h2>
<section id="anec70067-sec-0007"><h3 class="pmc_sec_title">2.1. Study Design</h3>
<p>The RYOUMA registry is a prospective multicenter observational study, and study design and primary outcome results have been reported previously (Nogami et al. <a href="#anec70067-bib-0009" class="usa-link" aria-describedby="anec70067-bib-0009">2022</a>). All patients with non‐valvular AF planning their first CA were eligible for inclusion. In this subanalysis, patients using warfarin or not using OAC before CA were excluded.</p>
<p>Baseline data were collected before the CA procedure. Thromboembolic risk was stratified using the CHADS2 score (congestive heart failure; hypertension; age ≥ 75 years; diabetes; previous stroke or transient ischemic attack (TIA) [doubled]) (Gage et al. <a href="#anec70067-bib-0002" class="usa-link" aria-describedby="anec70067-bib-0002">2001</a>) and the CHA2DS2‐VASc score (congestive heart failure; hypertension; age ≥ 75 years [doubled]; diabetes; previous stroke, TIA or thromboembolism [doubled]; vascular disease; age 65–74 years; and female) (Lip et al. <a href="#anec70067-bib-0006" class="usa-link" aria-describedby="anec70067-bib-0006">2010</a>). Bleeding risk was evaluated using the HAS‐BLED score (uncontrolled hypertension; renal dysfunction; liver dysfunction; prior stroke; previous bleeding; age &gt; 65 years; labile international normalized ratio; and aspirin use or alcohol consumption) (Pisters et al. <a href="#anec70067-bib-0010" class="usa-link" aria-describedby="anec70067-bib-0010">2010</a>). However, information on the factor “L,” lability of the international normalized ratio, was not calculated because this factor is inappropriate for patients taking DOACs. Bleeding risk was considered high if the HAS‐B(L)ED score was ≥ 3. The OAC status after CA was obtained at any serious adverse events (SAEs) or on the day of the last follow‐up.</p>
<p>All patients were classified into three groups according to their CHADS2 score (0–1, 2 and 3–6), as the Japanese guidelines recommend using the CHADS2 score (Class I) over the CHA2DS2‐VASc score (Class IIb). Baseline characteristics and clinical outcomes were compared among these three groups, along with their DOAC status.</p>
<p>This study was conducted in accordance with the principles of the Declaration of Helsinki, and the research protocol was approved by all applicable participating sites. All patients provided written informed consent before participating in the study. The study was registered as UMIN000026092 (University Hospital Medical Information Network‐Clinical Trial Registry). The study protocol also received approval from the ethical committee at each study site before the initiation of the registry (University of Tsukuba Hospital: H28‐219).</p></section><section id="anec70067-sec-0008"><h3 class="pmc_sec_title">2.2. Follow‐Up and Clinical Outcomes</h3>
<p>The primary outcomes assessed in this subanalysis were SAEs during the 1‐year follow‐up period. SAEs included ischemic stroke, systemic embolic events (SEEs), major bleeding, all‐cause death, cardiovascular deaths, cardiovascular adverse events, and intracranial hemorrhage. These events were evaluated by an event adjudication committee. Major bleeding events were defined according to the criteria of the International Society on Thrombosis Hemostasis (Schulman and Kearon <a href="#anec70067-bib-0011" class="usa-link" aria-describedby="anec70067-bib-0011">2005</a>). When SAEs occurred during the follow‐up period, case report forms (CRFs) were promptly submitted and evaluated by an event adjudication committee. We also collected follow‐up data at 1, 3, 6, and 12 months after the ablation procedure. All AEs, including SAEs, clinically relevant non‐major bleeding, and AF recurrence, were reported. The recurrence of AF was defined as any documented AF episode lasting over 30 s. All SAEs were evaluated by an event adjudication committee. Even in the absence of any adverse events, CRFs were collected by the clinical research coordinator. The timing and frequency of 24‐h Holter monitor and/or 2‐week event monitor implementation were left to the discretion of each attending physician.</p></section><section id="anec70067-sec-0009"><h3 class="pmc_sec_title">2.3. Statistical Analysis</h3>
<p>Continuous variables were presented as the median and interquartile ranges (IQRs). Categorical variables were summarized using <em>n</em> (%). Baseline characteristics were compared using the chi‐squared test for categorical variables and Wilcoxon's rank sum test for continuous variables. The cumulative event rates during the follow‐up period were estimated using the Kaplan–Meier method. The survival curves were compared using a log‐rank test. For each endpoint, the incidence rate of the event and 95% confidence intervals (CIs) were estimated. The incidence rates of the event were compared using risk difference. Cox proportional hazard regression analysis was used to assess the predictors in each factor of the CHADS2 score for ischemic stroke/SEEs. Statistical significance was defined as a two‐tailed <em>p</em> &lt; 0.05. Statistical analyses were conducted using SAS version 9.4 (SAS Institute Inc., Cary, NC, USA).</p></section></section><section id="anec70067-sec-0010"><h2 class="pmc_sec_title">3. Results</h2>
<section id="anec70067-sec-0011"><h3 class="pmc_sec_title">3.1. Patients Characteristics</h3>
<p>The patient flow diagram is presented in Figure <a href="#anec70067-fig-0001" class="usa-link">1</a>. For this subanalysis, a total of 2844 patients were included. Baseline patient characteristics are summarized in Table <a href="#anec70067-tbl-0001" class="usa-link">1</a>. The median age was 68.0 years, and 70.9% were men, with 64.0% of patients having paroxysmal AF. Among all patients, 35.7% had a CHADS2 score of ≥ 2, and 32.1% had a HAS‐B(L)ED score of ≥ 3. Types of DOACs included dabigatran (13.3%), rivaroxaban (27.6%), apixaban (26.9%), and edoxaban (32.2%).</p>
<figure class="fig xbox font-sm" id="anec70067-fig-0001"><h4 class="obj_head">FIGURE 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c858/11966009/7d595cdc6c65/ANEC-30-e70067-g004.jpg" loading="lazy" id="jats-graphic-3" height="491" width="709" alt="FIGURE 1"></p>
<div class="p text-right font-secondary"><a href="figure/anec70067-fig-0001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Patient flow diagram. OAC, oral anticoagulant.</p></figcaption></figure><section class="tw xbox font-sm" id="anec70067-tbl-0001"><h4 class="obj_head">TABLE 1.</h4>
<div class="caption p"><p>Baseline demographic and clinical characteristics of study patients.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<thead valign="bottom"><tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1"></th>
<th align="center" valign="bottom" rowspan="1" colspan="1">
<em>n</em> = 2844</th>
</tr></thead>
<tbody valign="top">
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Age, median [IQR], years</td>
<td align="center" valign="top" rowspan="1" colspan="1">68.0 [60.0–73.0]</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Male sex, <em>n</em> (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2016 (70.9)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Body weight, median [IQR], kg</td>
<td align="center" valign="top" rowspan="1" colspan="1">64.9 [56.9–73.7]</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">BMI, median [IQR], kg/m<sup>2</sup>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">23.8 [21.8–26.3]</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Creatinine clearance, median [IQR], mL/min</td>
<td align="center" valign="top" rowspan="1" colspan="1">76.9 [61.4–96.0]</td>
</tr>
<tr><td align="left" colspan="2" valign="top" rowspan="1">AF type</td></tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Paroxysmal, <em>n</em> (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1821 (64.0)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Persistent, <em>n</em> (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">711 (25.0)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Long‐standing persistent, <em>n</em> (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">312 (11.0)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">CHADS<sub>2</sub> score, median [IQR]</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.0 [0.0–2.0]</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">CHADS<sub>2</sub> score ≥ 2, <em>n</em> (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1016 (35.7)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">CHADS<sub>2</sub> score ≥ 1, <em>n</em> (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2062 (72.5)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">CHA<sub>2</sub>DS<sub>2</sub>‐VASc score, median [IQR]</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.0 [1.0–3.0]</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">CHA<sub>2</sub>DS<sub>2</sub>‐VASc score ≥ 3, <em>n</em> (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1191 (41.9)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">CHA<sub>2</sub>DS<sub>2</sub>‐VASc score ≥ 2, <em>n</em> (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1856 (65.3)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">HAS‐B(L)ED score, median [IQR]</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.0 [1.0–3.0]</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">HAS‐B(L)ED score ≥ 3, <em>n</em> (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">914 (32.1)</td>
</tr>
<tr><td align="left" colspan="2" valign="top" rowspan="1">Comorbidity, <em>n</em> (%)</td></tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Hypertension</td>
<td align="center" valign="top" rowspan="1" colspan="1">1722 (60.5)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Diabetes</td>
<td align="center" valign="top" rowspan="1" colspan="1">483 (17.0)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Heart disease</td>
<td align="center" valign="top" rowspan="1" colspan="1">756 (26.6)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Kidney disease</td>
<td align="center" valign="top" rowspan="1" colspan="1">229 (8.1)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Hemodialysis</td>
<td align="center" valign="top" rowspan="1" colspan="1">2 (0.1)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Hepatic disorder</td>
<td align="center" valign="top" rowspan="1" colspan="1">176 (6.2)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Cerebrovascular disease</td>
<td align="center" valign="top" rowspan="1" colspan="1">314 (11.0)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Thromboembolism</td>
<td align="center" valign="top" rowspan="1" colspan="1">98 (3.4)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Dementia</td>
<td align="center" valign="top" rowspan="1" colspan="1">15 (0.5)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Antiplatelets use, <em>n</em> (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">247 (8.7)</td>
</tr>
<tr><td align="left" colspan="2" valign="top" rowspan="1">Type of DOACs, <em>n</em> (%)</td></tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Dabigatran</td>
<td align="center" valign="top" rowspan="1" colspan="1">377 (13.3)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Rivaroxaban</td>
<td align="center" valign="top" rowspan="1" colspan="1">784 (27.6)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Apixaban</td>
<td align="center" valign="top" rowspan="1" colspan="1">766 (26.9)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Edoxaban</td>
<td align="center" valign="top" rowspan="1" colspan="1">917 (32.2)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/anec70067-tbl-0001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="anec70067-note-0002"><p>Abbreviations: AF, atrial fibrillation; BMI, body mass index; DOAC, direct‐acting oral anticoagulant; IQR, interquartile range.</p></div></div></section><p>In the previous report from the RYOUMA registry, the rate of OAC continuation in patients with DOAC was reported to decrease as the CHADS2 score decreased (Figure <a href="#anec70067-supitem-0001" class="usa-link">S1</a>) (Nogami et al. <a href="#anec70067-bib-0009" class="usa-link" aria-describedby="anec70067-bib-0009">2022</a>). The baseline characteristics according to the CHADS2 score categories and DOAC continuation status are shown in Table <a href="#anec70067-tbl-0002" class="usa-link">2</a>. The rate of DOAC continuation was 48.1%, 69.6%, and 80.9% in patients with a CHADS2 score of 0–1, 2, and 3–6, respectively. Among patients with a CHADS2 score of 0–1, those with DOAC continuation were older (67.0 years [IQR, 60.0–71.0] vs. 63.0 years [IQR, 54.0–69.0], <em>p</em> &lt; 0.001), had a lower proportion of males (70.6% vs. 76.4%, <em>p</em> = 0.005), lower body weight (65.2 kg [IQR, 56.6–74.2] vs. 66.5 kg [IQR, 59.2–74.5], <em>p</em> = 0.037), lower creatinine clearance (CrCl) (78.9 mL/min [IQR, 64.5–98.6] vs. 86.1 mL/min [IQR, 70.3–105.6], <em>p</em> &lt; 0.001), a lower proportion of paroxysmal AF (59.0% vs. 70.6%, <em>p</em> &lt; 0.001), a higher rate of anti‐arrhythmic drug (AAD) use (75.7% vs. 67.2%, <em>p</em> &lt; 0.001), and a higher rate of AF recurrence (12.6% vs. 6.5%, <em>p</em> &lt; 0.001) compared to those with DOAC discontinuation. The median scores of CHADS2, CHA2DS2‐VASc, and HAS‐B(L)ED were also higher in those with DOAC continuation compared to DOAC discontinuation (1.0 [IQR, 0.0–1.0] vs. 0.0 [IQR, 0.0–1.0], <em>p</em> &lt; 0.001; 2.0 [IQR, 1.0–2.0] vs. 1.0 [IQR, 0.0–2.0], <em>p</em> &lt; 0.001; and 2.0 [IQR, 1.0–2.0] vs. 1.0 [IQR, 1.0–2.0], <em>p</em> &lt; 0.001, respectively). Among patients with a CHADS2 score of 0–1, a higher CHA2DS2‐VASc score and AF recurrence are independent factors for DOAC continuation. In contrast, among patients with a CHADS2 score of 2, there were no significant differences between those with DOAC continuation and discontinuation. Among patients with a CHADS2 score of 3–6, the only observed difference was in the prevalence of malignancy.</p>
<section class="tw xbox font-sm" id="anec70067-tbl-0002"><h4 class="obj_head">TABLE 2.</h4>
<div class="caption p"><p>Baseline characteristics according to the CHADS<sub>2</sub> score categories and DOAC continuation status.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom">
<tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1">CHADS<sub>2</sub> score</th>
<th align="center" colspan="3" valign="bottom" rowspan="1">0–1</th>
<th align="center" colspan="3" valign="bottom" rowspan="1">2</th>
<th align="center" colspan="3" valign="bottom" rowspan="1">3–6</th>
</tr>
<tr style="border-bottom:solid 1px #000000">
<th align="left" rowspan="2" valign="bottom" colspan="1">DOAC status</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Continued</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Discontinued</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">
<p>
<em>p</em>
</p>
<p>Continued versus Discontinued</p>
</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Continued</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Discontinued</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">
<p>
<em>p</em>
</p>
<p>Continued versus Discontinued</p>
</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Continued</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Discontinued</th>
<th align="center" rowspan="2" valign="bottom" colspan="1">
<p>
<em>p</em>
</p>
<p>Continued versus Discontinued</p>
</th>
</tr>
<tr style="border-bottom:solid 1px #000000">
<th align="center" valign="bottom" rowspan="1" colspan="1">
<em>N</em> = 880</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">
<em>N</em> = 948</th>
<th align="center" valign="bottom" rowspan="1" colspan="1"></th>
<th align="center" valign="bottom" rowspan="1" colspan="1">
<em>N</em> = 441</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">
<em>N</em> = 193</th>
<th align="center" valign="bottom" rowspan="1" colspan="1"></th>
<th align="center" valign="bottom" rowspan="1" colspan="1">
<em>N</em> = 309</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">
<em>N</em> = 73</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Age, median [IQR], years</td>
<td align="center" valign="top" rowspan="1" colspan="1">67.0 [60.0–71.0]</td>
<td align="center" valign="top" rowspan="1" colspan="1">63.0 [54.0–69.0]</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> &lt; 0.001</td>
<td align="center" valign="top" rowspan="1" colspan="1">72.0 [66.0–77.0]</td>
<td align="center" valign="top" rowspan="1" colspan="1">70.0 [63.0–77.0]</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.109</td>
<td align="center" valign="top" rowspan="1" colspan="1">75.0 [69.0–78.0]</td>
<td align="center" valign="top" rowspan="1" colspan="1">75.0 [71.0–80.0]</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.154</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Male sex, <em>n</em> (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">621 (70.6)</td>
<td align="center" valign="top" rowspan="1" colspan="1">724 (76.4)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.005</td>
<td align="center" valign="top" rowspan="1" colspan="1">283 (64.2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">129 (66.8)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.517</td>
<td align="center" valign="top" rowspan="1" colspan="1">210 (68.0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">49 (67.1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.890</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Body weight, median [IQR], kg</td>
<td align="center" valign="top" rowspan="1" colspan="1">65.2 [56.6–74.2]</td>
<td align="center" valign="top" rowspan="1" colspan="1">66.5 [59.2–74.5]</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.037</td>
<td align="center" valign="top" rowspan="1" colspan="1">63.6 [56.2–72.2]</td>
<td align="center" valign="top" rowspan="1" colspan="1">62.8 [56.8–75.1]</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.586</td>
<td align="center" valign="top" rowspan="1" colspan="1">62.3 [55.0–71.0]</td>
<td align="center" valign="top" rowspan="1" colspan="1">61.5 [54.0–70.9]</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.500</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">BMI, median [IQR], kg/m<sup>2</sup>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">23.9 [21.7–26.3]</td>
<td align="center" valign="top" rowspan="1" colspan="1">23.7 [21.7–25.8]</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.237</td>
<td align="center" valign="top" rowspan="1" colspan="1">24.0 [22.0–27.2]</td>
<td align="center" valign="top" rowspan="1" colspan="1">24.3 [21.6–26.7]</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.691</td>
<td align="center" valign="top" rowspan="1" colspan="1">23.8 [21.9–26.6]</td>
<td align="center" valign="top" rowspan="1" colspan="1">23.7 [21.3–25.9]</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.450</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Creatinine clearance, median [IQR], mL/min</td>
<td align="center" valign="top" rowspan="1" colspan="1">78.9 [64.5–98.6]</td>
<td align="center" valign="top" rowspan="1" colspan="1">86.1 [70.3–105.6]</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> &lt; 0.001</td>
<td align="center" valign="top" rowspan="1" colspan="1">70.1 [54.4–86.20]</td>
<td align="center" valign="top" rowspan="1" colspan="1">71.8 [57.1–92.8]</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.188</td>
<td align="center" valign="top" rowspan="1" colspan="1">63.9 [50.1–76.3]</td>
<td align="center" valign="top" rowspan="1" colspan="1">56.7 [48.9–78.7]</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.192</td>
</tr>
<tr><td align="left" colspan="10" valign="top" rowspan="1">AF type</td></tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Paroxysmal, <em>n</em> (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">519 (59.0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">669 (70.6)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> &lt; 0.001</td>
<td align="center" valign="top" rowspan="1" colspan="1">275 (62.4)</td>
<td align="center" valign="top" rowspan="1" colspan="1">124 (64.2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.677</td>
<td align="center" valign="top" rowspan="1" colspan="1">184 (59.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">50 (68.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.277</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Persistent, <em>n</em> (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">239 (27.2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">200 (21.1)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">119 (27.0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">46 (23.8)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">92 (29.8)</td>
<td align="center" valign="top" rowspan="1" colspan="1">15 (20.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Long‐standing persistent, <em>n</em> (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">122 (13.9)</td>
<td align="center" valign="top" rowspan="1" colspan="1">79 (8.3)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">47 (10.7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">23 (11.9)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">33 (10.7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">8 (11.0)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">AAD use, <em>n</em> (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">666 (75.7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">637 (67.2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> &lt; 0.001</td>
<td align="center" valign="top" rowspan="1" colspan="1">331 (75.1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">133 (68.9)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.108</td>
<td align="center" valign="top" rowspan="1" colspan="1">238 (77.0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">60 (82.2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.338</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">AF recurrence, <em>n</em> (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">111 (12.6)</td>
<td align="center" valign="top" rowspan="1" colspan="1">62 (6.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> &lt; 0.001</td>
<td align="center" valign="top" rowspan="1" colspan="1">43 (9.8)</td>
<td align="center" valign="top" rowspan="1" colspan="1">12 (6.2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.146</td>
<td align="center" valign="top" rowspan="1" colspan="1">28 (9.1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">7 (9.6)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.889</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">CHADS<sub>2</sub> score, median [IQR]</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.0 [0.0–1.0]</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0 [0.0–1.0]</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> &lt; 0.001</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.0 [2.0–2.0]</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.0 [2.0–2.0]</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 1.000</td>
<td align="center" valign="top" rowspan="1" colspan="1">3.0 [3.0–4.0]</td>
<td align="center" valign="top" rowspan="1" colspan="1">3.0 [3.0–4.0]</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.838</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">CHA<sub>2</sub>DS<sub>2</sub>‐VASc score, median [IQR]</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.0 [1.0–2.0]</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.0 [0.0–2.0]</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> &lt; 0.001</td>
<td align="center" valign="top" rowspan="1" colspan="1">3.0 [3.0–4.0]</td>
<td align="center" valign="top" rowspan="1" colspan="1">3.0 [3.0–4.0]</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.169</td>
<td align="center" valign="top" rowspan="1" colspan="1">5.0 [4.0–5.0]</td>
<td align="center" valign="top" rowspan="1" colspan="1">5.0 [4.0–6.0]</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.426</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">HAS‐B(L)ED score, median [IQR]</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.0 [1.0–2.0]</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.0 [1.0–2.0]</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> &lt; 0.001</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.0 [2.0–3.0]</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.0 [2.0–3.0]</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.768</td>
<td align="center" valign="top" rowspan="1" colspan="1">3.0 [3.0–4.0]</td>
<td align="center" valign="top" rowspan="1" colspan="1">3.0 [2.0–5.0]</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.457</td>
</tr>
<tr><td align="left" colspan="10" valign="top" rowspan="1">Comorbidity, <em>n</em> (%)</td></tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Hypertension</td>
<td align="center" valign="top" rowspan="1" colspan="1">454 (51.6)</td>
<td align="center" valign="top" rowspan="1" colspan="1">386 (40.7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> &lt; 0.001</td>
<td align="center" valign="top" rowspan="1" colspan="1">372 (84.4)</td>
<td align="center" valign="top" rowspan="1" colspan="1">165 (85.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.714</td>
<td align="center" valign="top" rowspan="1" colspan="1">280 (90.6)</td>
<td align="center" valign="top" rowspan="1" colspan="1">65 (89.0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.683</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Diabetes</td>
<td align="center" valign="top" rowspan="1" colspan="1">28 (3.2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">27 (2.8)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.676</td>
<td align="center" valign="top" rowspan="1" colspan="1">164 (37.2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">67 (34.7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.552</td>
<td align="center" valign="top" rowspan="1" colspan="1">163 (52.8)</td>
<td align="center" valign="top" rowspan="1" colspan="1">34 (46.6)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.342</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Heart disease</td>
<td align="center" valign="top" rowspan="1" colspan="1">185 (21.0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">104 (11.0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> &lt; 0.001</td>
<td align="center" valign="top" rowspan="1" colspan="1">169 (38.3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">80 (41.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.458</td>
<td align="center" valign="top" rowspan="1" colspan="1">182 (58.9)</td>
<td align="center" valign="top" rowspan="1" colspan="1">36 (49.3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.137</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Kidney disease</td>
<td align="center" valign="top" rowspan="1" colspan="1">44 (5.0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">59 (6.2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.257</td>
<td align="center" valign="top" rowspan="1" colspan="1">44 (10.0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">21 (10.9)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.730</td>
<td align="center" valign="top" rowspan="1" colspan="1">50 (16.2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">11 (15.1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.815</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Hepatic disorder</td>
<td align="center" valign="top" rowspan="1" colspan="1">45 (5.1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">58 (6.1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.352</td>
<td align="center" valign="top" rowspan="1" colspan="1">37 (8.4)</td>
<td align="center" valign="top" rowspan="1" colspan="1">14 (7.3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.628</td>
<td align="center" valign="top" rowspan="1" colspan="1">18 (5.8)</td>
<td align="center" valign="top" rowspan="1" colspan="1">4 (5.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.909</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Cerebrovascular disease</td>
<td align="center" valign="top" rowspan="1" colspan="1">16 (1.8)</td>
<td align="center" valign="top" rowspan="1" colspan="1">11 (1.2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.244</td>
<td align="center" valign="top" rowspan="1" colspan="1">47 (10.7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">19 (9.8)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.758</td>
<td align="center" valign="top" rowspan="1" colspan="1">177 (57.3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">44 (60.3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.641</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Thromboembolism</td>
<td align="center" valign="top" rowspan="1" colspan="1">20 (2.3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">12 (1.3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.101</td>
<td align="center" valign="top" rowspan="1" colspan="1">21 (4.8)</td>
<td align="center" valign="top" rowspan="1" colspan="1">10 (5.2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.822</td>
<td align="center" valign="top" rowspan="1" colspan="1">25 (8.1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">10 (13.7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.135</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Malignancy</td>
<td align="center" valign="top" rowspan="1" colspan="1">65 (7.4)</td>
<td align="center" valign="top" rowspan="1" colspan="1">63 (6.6)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.535</td>
<td align="center" valign="top" rowspan="1" colspan="1">66 (15.0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">36 (18.7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.245</td>
<td align="center" valign="top" rowspan="1" colspan="1">41 (13.3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">18 (24.7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.015</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Dementia</td>
<td align="center" valign="top" rowspan="1" colspan="1">2 (0.2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0 (0.0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.142</td>
<td align="center" valign="top" rowspan="1" colspan="1">4 (0.9)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (0.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.610</td>
<td align="center" valign="top" rowspan="1" colspan="1">5 (1.6)</td>
<td align="center" valign="top" rowspan="1" colspan="1">3 (4.1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.181</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Antiplatelet use, <em>n</em> (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">44 (5.0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">35 (3.7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.169</td>
<td align="center" valign="top" rowspan="1" colspan="1">57 (12.9)</td>
<td align="center" valign="top" rowspan="1" colspan="1">20 (10.4)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.363</td>
<td align="center" valign="top" rowspan="1" colspan="1">74 (23.9)</td>
<td align="center" valign="top" rowspan="1" colspan="1">17 (23.3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.905</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Hemoglobin, median [IQR], g/dL</td>
<td align="center" valign="top" rowspan="1" colspan="1">14.2 [13.1–15.2]</td>
<td align="center" valign="top" rowspan="1" colspan="1">14.3 [13.5–15.5]</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> &lt; 0.001</td>
<td align="center" valign="top" rowspan="1" colspan="1">13.7 [12.6–14.9]</td>
<td align="center" valign="top" rowspan="1" colspan="1">13.9 [12.8–14.8]</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.482</td>
<td align="center" valign="top" rowspan="1" colspan="1">13.7 [12.7–14.7]</td>
<td align="center" valign="top" rowspan="1" colspan="1">13.3 [12.3–14.6]</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.178</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">HbA1c (NGSP), median [IQR], %</td>
<td align="center" valign="top" rowspan="1" colspan="1">5.7 [5.5–6.0]</td>
<td align="center" valign="top" rowspan="1" colspan="1">5.7 [5.4–5.9]</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.013</td>
<td align="center" valign="top" rowspan="1" colspan="1">6.0 [5.7–6.8]</td>
<td align="center" valign="top" rowspan="1" colspan="1">6.0 [5.6–6.5]</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.141</td>
<td align="center" valign="top" rowspan="1" colspan="1">6.2 [5.8–6.8]</td>
<td align="center" valign="top" rowspan="1" colspan="1">6.1 [5.6–6.6]</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.153</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/anec70067-tbl-0002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="anec70067-note-0003"><p>Abbreviations: AAD, anti‐arrhythmic drug; NGSP, national glycohemoglobin standardization program; other abbreviations are as in Table <a href="#anec70067-tbl-0001" class="usa-link">1</a>.</p></div></div></section></section><section id="anec70067-sec-0012"><h3 class="pmc_sec_title">3.2. Clinical Outcomes</h3>
<p>In this study, 2630 out of 2844 patients (92.5%) completed the one‐year follow‐up period. In terms of the primary endpoint, adjudicated ischemic stroke/SEEs occurred in seven patients, major bleeding events occurred in 31, and all‐cause death occurred in 12 during the 1‐year post‐ablation period starting from postoperative day 30. Among the seven patients with ischemic stroke/SEEs, two had atherothrombotic or lacunar infarction, three had hemorrhagic infarction, and two had cardioembolic infarction. Of the 31 patients with major bleeding events, eight patients had intracranial hemorrhage, and 23 patients had other bleeding. Details of major bleeding events are shown in Table <a href="#anec70067-supitem-0001" class="usa-link">S1</a>, and details of all‐cause deaths and DOAC status are shown in Table <a href="#anec70067-supitem-0001" class="usa-link">S2</a>. The cumulative event rates of ischemic stroke/SEEs and major bleeding events at 1 year were 0.26% (95% CI, 0.12–0.54) and 1.14% (95% CI, 0.80–1.61), respectively (Figure <a href="#anec70067-fig-0002" class="usa-link">2</a>). The number of each SAE, categorized by CHADS2 score, was presented in Table <a href="#anec70067-tbl-0003" class="usa-link">3</a>, distinguishing between those taking DOAC and those not taking DOAC at any SAEs or on the day of the last follow‐up. All seven patients who experienced ischemic stroke/SEEs were on DOACs: three patients with a CHADS2 score of 0–1, one patient with a CHADS2 score of 2, and three patients with a CHADS2 score of 3–6. No cases of ischemic stroke/SEEs were observed in patients not taking DOACs. Among patients taking DOACs, the incidence rates of major bleeding events were significantly higher than those of ischemic stroke/SEEs in the patients with a CHADS2 score of 0–1 (1.3%/year [95% CI, 0.6–2.1] vs. 0.3%/year [95% CI, 0.0–0.7], <em>p</em> = 0.019) and in patients with a CHADS2 score of 2 (1.8%/year [95% CI, 0.6–3.0] vs. 0.2%/year [95% CI, 0.0–0.6], <em>p</em> = 0.018) (Figure <a href="#anec70067-fig-0003" class="usa-link">3A</a>). On the other hand, among patients with a CHADS2 score of 3–6, there was no difference between the incidence rate of major bleeding and ischemic stroke/SEEs (1.6%/year [95% CI, 0.2–3.0] vs. 1.0%/year [95% CI, 0.0–2.1], <em>p</em> = 0.47). Among patients not taking DOACs, the incidence rates of major bleeding were very low in those with a CHADS2 score of 0–1 (0.4%/year [95% CI, 0.0–0.8]) and with a CHADS2 score of 2 (0%/year), although in those with a CHADS2 score of 3–6, that was very high (6.0%/year [95% CI, 0.0–12.6]) (Figure <a href="#anec70067-fig-0003" class="usa-link">3B</a>). In terms of all‐cause mortality, for patients with a CHADS2 score of 3–6, the mortality rate was higher compared to patients with a CHADS2 score of 0–1 or 2. The number of major bleeding events, categorized as intracranial hemorrhage or other major bleeding based on CHADS2 scores, is shown in Table <a href="#anec70067-supitem-0001" class="usa-link">S3</a>. Among the eight patients who experienced intracranial hemorrhage, six were on DOACs: five had a CHADS2 score of 0–1, and one had a CHADS2 score of 2. Two patients were not taking DOACs and had a CHADS2 score of 3–6. One patient with cerebral hemorrhage, who was taking DOACs and had a CHADS2 score of 2, died as a result of the hemorrhage.</p>
<figure class="fig xbox font-sm" id="anec70067-fig-0002"><h4 class="obj_head">FIGURE 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c858/11966009/edf3ec70c407/ANEC-30-e70067-g002.jpg" loading="lazy" id="jats-graphic-5" height="293" width="709" alt="FIGURE 2"></p>
<div class="p text-right font-secondary"><a href="figure/anec70067-fig-0002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Kaplan–Meier plot of the time to the first serious adverse event. (A) The cumulative event rate of ischemic stroke/SEEs. (B) The cumulative event rate of major bleeding events. SEE, systemic embolic event; other abbreviations as in Figure <a href="#anec70067-fig-0001" class="usa-link">1</a>.</p></figcaption></figure><section class="tw xbox font-sm" id="anec70067-tbl-0003"><h4 class="obj_head">TABLE 3.</h4>
<div class="caption p"><p>Serious adverse events after ablation by CHADS<sub>2</sub> score categories (overall patients).</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom">
<tr style="border-bottom:solid 1px #000000">
<th align="left" rowspan="2" valign="bottom" colspan="1">CHADS<sub>2</sub> score</th>
<th align="center" colspan="3" valign="bottom" rowspan="1">
<p>Events while taking DOACs</p>
<p>No. of events</p>
<p>(% per Year [95% CI])</p>
</th>
<th align="center" colspan="3" valign="bottom" rowspan="1">
<p>Events while taking No DOAC</p>
<p>No. of events</p>
<p>(% per Year [95% CI])</p>
</th>
</tr>
<tr style="border-bottom:solid 1px #000000">
<th align="center" valign="bottom" rowspan="1" colspan="1">Ischemic stroke/SEEs</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Major bleeding</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">All‐cause death</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Ischemic stroke/SEEs</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Major bleeding</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">All‐cause death</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>0–1</p>
<p>(<em>n</em> = 1828)</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>3</p>
<p>(0.3 [0.0–0.7])</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>12</p>
<p>(1.3 [0.6–2.1])</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>1</p>
<p>(0.1 [0.0–0.3])</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>0</p>
<p>NC</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>3</p>
<p>(0.4 [0.0–0.8])</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>2</p>
<p>(0.2 [0.0–0.6])</p>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>2</p>
<p>(<em>n</em> = 634)</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>1</p>
<p>(0.2 [0.0–0.6])</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>8</p>
<p>(1.8 [0.6–3.0])</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>2</p>
<p>(0.4 [0.0–1.0])</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>0</p>
<p>NC</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>0</p>
<p>NC</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>2</p>
<p>(1.3 [0.0–3.1])</p>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>3–6</p>
<p>(<em>n</em> = 382)</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>3</p>
<p>(1.0 [0.0–2.1])</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>5</p>
<p>(1.6 [0.2–3.0])</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>2</p>
<p>(0.6 [0.0–1.5])</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>0</p>
<p>NC</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>3</p>
<p>(6.0 [0.0–12.6])</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>3</p>
<p>(5.6 [0.0–11.8])</p>
</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/anec70067-tbl-0003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="anec70067-note-0004"><p>Abbreviations: NC, not calculated; SEE, systemic embolic eventother abbreviations as in Table <a href="#anec70067-tbl-0001" class="usa-link">1</a>.</p></div></div></section><figure class="fig xbox font-sm" id="anec70067-fig-0003"><h4 class="obj_head">FIGURE 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c858/11966009/4c6e937bfae4/ANEC-30-e70067-g001.jpg" loading="lazy" id="jats-graphic-7" height="344" width="709" alt="FIGURE 3"></p>
<div class="p text-right font-secondary"><a href="figure/anec70067-fig-0003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Serious adverse events per year of follow‐up after ablation by CHADS2 score categories (overall patients). (A) Events while taking DOACs. (B) Events while not taking DOACs. Error bars denote the upper bound of 95% CIs. DOAC, direct‐acting oral anticoagulant; other abbreviations are as in Figures <a href="#anec70067-fig-0001" class="usa-link">1</a> and <a href="#anec70067-fig-0002" class="usa-link">2</a>.</p></figcaption></figure><p>To eliminate the influence of antiplatelet therapy, we analyzed the subgroup not receiving antiplatelet therapy (<em>n</em> = 2597) (Table <a href="#anec70067-supitem-0001" class="usa-link">S4</a>). Among patients taking DOACs with a CHADS2 score of 0–1 or 2, the incidence rates of SAEs were similar to the overall patient trend, and the incidence rates of major bleeding events were significantly higher than those of ischemic stroke/SEEs (CHADS2 score 0–1: 1.3%/year [95% CI, 0.5–2.0] vs. 0.3%/year [95% CI, 0.0–0.7], <em>p</em> = 0.031; CHADS2 score 2: 1.8%/year [95% CI, 0.5–3.1] vs. 0.3%/year [95% CI, 0.0–0.7], <em>p</em> = 0.032, respectively). However, among patients with a CHADS2 score of 3–6, the incidence rate of major bleeding events was the same as that of ischemic stroke/SEEs (1.3%/year [95% CI, 0.0–2.7] vs. 1.3%/year [95% CI, 0.0–2.7]) (Figure <a href="#anec70067-supitem-0001" class="usa-link">S2</a>). Among patients not taking DOACs, the trend was the same as in the overall population, but the incidence of major bleeding and overall mortality decreased.</p>
<p>In the CHA2DS2‐VASc score classification and HAS‐B(L)ED score classification, identifying a group with a low thromboembolic risk but a high bleeding risk (as in patients with a CHADS2 score of 2) among individuals taking DOACs proved challenging (Figures <a href="#anec70067-supitem-0001" class="usa-link">S3</a> and <a href="#anec70067-supitem-0001" class="usa-link">S4</a>).</p>
<p>SAEs by the individual CHADS2 factors are depicted in Figure <a href="#anec70067-supitem-0001" class="usa-link">S5</a> and Table <a href="#anec70067-supitem-0001" class="usa-link">S5</a>. Among patients who continued taking DOACs, those with “S” factor have a higher incidence rate of ischemic stroke/SEEs (1.0%/year [95% CI, 0.0–2.3]) compared to patients with other CHADS2 factors (0.3%–0.5%/year). However, due to the low number of events, statistical comparison of incidence rates between the patients with “S” factor and those with other factors of a CHADS2 score could not be performed.</p></section></section><section id="anec70067-sec-0013"><h2 class="pmc_sec_title">4. Discussion</h2>
<p>This is the first prospective study assessing the risk of ischemic stroke and major bleeding events in patients with AF who continued or discontinued DOAC treatment after CA. The main findings of this study are as follows:
</p>
<ol id="anec70067-list-0001" class="list" style="list-style-type:decimal">
<li id="anec70067-li-0001"><p>In patients with a CHADS2 score of 0–1, those who continued taking DOACs were significantly older, had a lower proportion of males, lower body weight, and a lower prevalence of paroxysmal AF, a higher rate of AAD use, and a higher rate of AF recurrence compared to those who discontinued DOACs. Conversely, in patients with a CHADS2 score of 2, there were no significant differences between those continuing DOACs and those discontinuing.</p></li>
<li id="anec70067-li-0002"><p>In patients with a CHADS2 score of 0–1 and 2, the incidence rate of ischemic stroke/SEEs at 1 year was notably low regardless of DOAC intake.</p></li>
<li id="anec70067-li-0003"><p>In patients with a CHADS2 score of 2, those who continued taking DOACs had a higher incidence rate of major bleeding events than ischemic stroke/SEEs, similar to those with a CHADS2 score of 0–1.</p></li>
<li id="anec70067-li-0004"><p>Among patients with a CHADS2 score of 3–6, there was no difference between the incidence rate of major bleeding events and that of ischemic stroke/SEEs in those who continued taking DOACs.</p></li>
</ol>
<p>We consider that the differences in patients with a CHADS2 score of 0–1 might be based on risk factors for ischemic stroke/SEEs other than the CHADS2 score and AF recurrence. Japanese guidelines describe low body weight, low CrCl, and persistent AF as risk factors for ischemic stroke/SEEs other than the CHADS2 score. AF recurrence is also likely a significant factor in a physician's decision to continue DOACs in patients even with a low risk of thromboembolism. This might have been more about continuing DOACs in preparation for the second ablation session rather than for preventing thromboembolism in patients with a low risk of thromboembolism.</p>
<p>In this study, ischemic stroke/SEEs occurred in patients who continued taking DOACs, whereas no ischemic stroke/SEEs were observed in those who discontinued taking DOACs. Furthermore, several major bleeding events occurred in patients who discontinued DOACs. This trend appeared paradoxical. The reasons and decision‐making processes for discontinuing or continuing DOAC therapy were not elucidated in the entire population of this study; however, each physician likely considered the balance of risks between ischemic stroke/SEEs and major bleeding events. In fact, several patients experienced ischemic stroke/SEEs despite continuing DOAC therapy. These patients were unable to prevent events solely by continuing DOACs and may have required additional preventive measures. Additionally, patients who discontinued DOACs despite having a CHADS2 score of 3–6 might have included those unable to continue due to a higher bleeding risk compared to ischemic stroke/SEEs. Unfortunately, we could not ascertain this reason due to the lack of significant differences in background characteristics between those who continued or discontinued DOACs, except for the presence of malignancy. Nevertheless, physicians who chose to discontinue DOAC therapy for patients with a CHADS2 score of 3–6 likely based their decisions on clear evidence, considering these patients at higher risk for major bleeding events despite their CHADS2 score. Even with the discontinuation of DOAC therapy, we considered that these patients could not prevent major bleeding events due to other risk factors associated with such events.</p>
<p>In this study, the cumulative incidence rate of ischemic stroke/SEEs tended to be lower, while the incidence rate of major bleeding events tended to be higher compared to some previous studies. For example, in the Chinese AF Ablation Registry (Yang et al. <a href="#anec70067-bib-0013" class="usa-link" aria-describedby="anec70067-bib-0013">2020</a>), the incidence rates for thromboembolism were 0.54 and 0.86 per 100 patient‐years, and the incidence rates for major bleeding events were 0.19 and 0.35 for the Off‐OAC (70%) and On‐OAC (30%) groups, respectively. Similarly, a Danish study (Karasoy et al. <a href="#anec70067-bib-0005" class="usa-link" aria-describedby="anec70067-bib-0005">2015</a>) reported incidence rates for thromboembolism and major bleeding events of 0.60 and 0.73 per 100 patient‐years, respectively. Possible reasons for our lower incidence rate of SEEs may be the high quality of AF ablation therapy and the high rate of DOAC continuation in Japan. On the other hand, the higher incidence rate of major bleeding events in our study may be attributed to the continuing DOACs in patients with a lower thromboembolic risk, as well as the difference in the definition of major bleeding events. We used sensitive criteria from the International Society on Thrombosis and Hemostasis and conducted a reliable follow‐up in our prospective study.</p>
<p>Recently, a large retrospective analysis from the National Database of Health Insurance Claims and Specific Health Checkups of Japan was reported (Kanaoka et al. <a href="#anec70067-bib-0004" class="usa-link" aria-describedby="anec70067-bib-0004">2024</a>). In this analysis, at 6 months after CA, OAC had been discontinued in 29%. There was a higher continuation rate of OAC therapy in the group with higher CHADS2 scores, and continuing OAC therapy was associated with a higher risk of major bleeding in patients with a CHADS2 score ≤ 2 and a lower risk of thromboembolism in patients with a CHADS2 score ≥ 3. While the definition of OAC status after ablation (classified based on the status 6 months after ablation) differs from that of our current study (classified based on the occurrence of any SAEs or on the last follow‐up date), the trends of main results are comparable, suggesting that patients with a CHADS2 score ≤ 2 may be considered for the possibility of discontinuation of DOACs. Meta‐analyses revealed no significant differences between patients who continued or discontinued OAC therapy regarding the risk of stroke/SEEs, although OAC continuation was associated with an increased risk of major bleeding (Atti et al. <a href="#anec70067-bib-0001" class="usa-link" aria-describedby="anec70067-bib-0001">2018</a>; Liu et al. <a href="#anec70067-bib-0007" class="usa-link" aria-describedby="anec70067-bib-0007"><sup>2021</sup></a>). A Danish registry (Karasoy et al. <a href="#anec70067-bib-0005" class="usa-link" aria-describedby="anec70067-bib-0005">2015</a>) also reported that the rates of thromboembolic events were similarly low among patients who discontinued and continued OAC therapy (0.56 and 0.64%/year, respectively), and continued OAC therapy was significantly associated with serious bleeding risk (hazard ratio 2.05). They concluded that the serious bleeding risk associated with OAC appeared to outweigh the benefits of thromboembolism reduction. However, major bleeding events are rarely life‐threatening, whereas stroke events are often life‐altering in general. Therefore, the severity of these SAEs and long‐term outcomes, including residual disability, should be considered alongside their incidence rates when evaluating clinical outcomes. Unfortunately, this study lacks detailed information on the severity and long‐term outcomes. Further research might be needed for optimal OAC therapy for the patients with a CHADS2 score ≤ 2 after CA.</p>
<p>For the patients with a CHADS2 score of 3–6, DOAC continuation after CA had been generally recommended for preventing ischemic stroke regardless of rhythm status. However, the latest expert consensus statement (Tzeis et al. <a href="#anec70067-bib-0012" class="usa-link" aria-describedby="anec70067-bib-0012">2024</a>) suggests that the discontinuation of anticoagulation is being considered based on strong patient values and preferences, and left atrial appendage occlusion may be discussed as an alternative approach. The present study showed the incidence rate of major bleeding events was higher and comparable to that of ischemic stroke/SEEs in the patients with a CHADS2 score of 3–6 who continued taking DOACs. Those patients should have a risk of ischemic stroke and also of major bleeding events; the optimal comprehensive management for preventing both events should be considered in the future.</p>
<section id="anec70067-sec-0014"><h3 class="pmc_sec_title">4.1. Limitations</h3>
<p>This study possesses several limitations. Firstly, it was not a randomized trial. The decision to continue or discontinue anticoagulation after CA was left to the discretion of individual physicians, and the underlying processes or reasons guiding this decision‐making remained unknown. Secondly, the findings of this study should be interpreted cautiously due to the low number of events and the small sample size. Multivariate analysis adjusting for clinical risk factors could not be performed because of the limited number of events. Additionally, the relative risk of ischemic stroke/SEEs could not be calculated, as no cases of ischemic stroke/SEEs were observed in patients not taking DOACs. Thirdly, the dosage of each DOAC was not taken into account in this analysis. Off‐label overdosing or underdosing may impact the incidence of clinical events. Fourthly, the recurrence rate of AF might not have been sufficiently detected. We did not utilize a 2‐week event monitor for all patients, which may have resulted in inadequate detection of asymptomatic AF. The AF recurrence rate in our study was lower than in previous reports. Lastly, a significant limitation is the short follow‐up period despite its prospective nature. Our analysis focused on clinical outcomes within 1 year after CA, and long‐term outcomes beyond this period were not examined. The latest expert consensus statement (Tzeis et al. <a href="#anec70067-bib-0012" class="usa-link" aria-describedby="anec70067-bib-0012">2024</a>) suggests deferral of OAC discontinuation until the completion of 12 months following CA in the intermediate‐risk patients to increase the likelihood of selecting patients with truly successful AF elimination. Furthermore, considering that the risk factors for thromboembolism may evolve over time, prolonged patient observation is imperative to assess the necessity of OAC therapy at each time point.</p></section></section><section id="anec70067-sec-0015"><h2 class="pmc_sec_title">5. Conclusions</h2>
<p>In this subanalysis of a large multicenter prospective registry, the DOAC continuation rate at 1 year after CA was 48.1%, 69.6%, and 80.9% in patients with a CHADS2 score of 0–1, 2, and 3–6, respectively. In patients with a CHADS2 score of 0–1 and 2, the incidence rate of ischemic stroke/SEEs at 1 year after CA was notably low regardless of DOAC intake. In patients with a CHADS2 score of 2, the incidence rate of major bleeding events appeared to be higher than that of ischemic stroke/SEEs among those who continued taking DOACs, resembling the trend observed in patients with a CHADS2 score of 0–1. Conversely, in patients with a CHADS2 score of 3–6, the incidence rates of both ischemic stroke/SEEs and major bleeding events seemed to be comparably high. Further research is needed to evaluate the safety and risks associated with the discontinuation of DOACs after successful CA.</p></section><section id="anec70067-sec-1002"><h2 class="pmc_sec_title">Author Contributions</h2>
<p>Conceptualization: Akihiko Nogami. Methodology: Yuka Oda, Akihiko Nogami. Writing – original draft preparation: Yuka Oda. Writing – review and editing: Akihiko Nogami. Statistical analysis: Masahiko Gosho. Funding acquisition: Masayuki Fukuzawa, Atsushi Takita. Resources: Yuki Komatsu, Kyoko Soejima, Itsuro Morishima, Kenichi Hiroshima, Ritsushi Kato, Satoru Sakagami, Fumiharu Miura, Keisuke Okawa, Kikuya Uno, Koichiro Kumagai, Takashi Kurita. Supervision: Tomoko Ishizu, Kazutaka Aonuma.</p></section><section id="anec70067-sec-0017"><h2 class="pmc_sec_title">Ethics Statement</h2>
<p>The study protocol also received approval from the ethical committee at each study site before the initiation of the registry (University of Tsukuba Hospital: H28‐219).</p></section><section id="anec70067-sec-0018"><h2 class="pmc_sec_title">Consent</h2>
<p>All patients provided written informed consent before participating in the study.</p></section><section id="anec70067-sec-0019"><h2 class="pmc_sec_title">Conflicts of Interest</h2>
<p>Akihiko Nogami has received honoraria from Boehringer Ingelheim, DAIICHI SANKYO, Bristol Myers Squibb, Abbott, and Johnson &amp; Johnson; and endowments from Medtronic. Yuki Komatsu has received honoraria from Johnson &amp; Johnson. Kyoko Soejima has received honoraria from Boehringer Ingelheim, DAIICHI SANKYO, Abbott, Medtronic, and Johnson &amp; Johnson. Itsuro Morishima has received honoraria from DAIICHI SANKYO and Abbott. Kenichi Hiroshima has received honoraria from Abbott, Medtronic, Boston, Johnson &amp; Johnson, and Japan Lifeline. Ritsushi Kato has received grant support from Boston Scientific, Abbott, Bayer, and Japan Lifeline. Satoru Sakagami has received honoraria from DAIICHI SANKYO and Johnson &amp; Johnson. Fumiharu Miura has received honoraria from Medtronic, Abbott, and Biotronik. Keisuke Okawa has received honoraria from Bayer, Boehringer Ingelheim, Bristol‐Myers Squibb, DAIICHI SANKYO, Pfizer, Abbott, Johnson &amp; Johnson, and Medtronic. Masayuki Fukuzawa and Atsushi Takita are employees of DAIICHI SANKYO. Kikuya Uno has received honoraria from Japan Lifeline. Koichiro Kumagai has received honoraria from DAIICHI SANKYO, Boehringer Ingelheim, and Japan Lifeline. Takashi Kurita has received honoraria from Bayer, Boehringer Ingelheim, DAIICHI SANKYO, Bristol‐Myers Squibb, Abbott, Medtronic, Japan Lifeline, and Johnson &amp; Johnson. Masahiko Gosho has received honoraria from Pfizer, Ferring Pharma, Merck Biopharma, and AstraZeneca. Tomoko Ishizu has received honoraria from Ono Pharmaceutical, Janssen Pharma, AstraZeneca, and Otsuka Pharmaceutical. Kazutaka Aonuma has received honoraria from Boston Scientific, Japan Lifeline, Nihon Kohden, Biotronik, Toray Industries, Abbott, Boehringer Ingelheim, and Century Medical.</p></section><section id="sec20"><h2 class="pmc_sec_title">Supporting information</h2>
<section class="sm xbox font-sm" id="anec70067-supitem-0001"><div class="caption p"><p>
<strong>Appendix S1.</strong> Supporting Information.</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/11966009/bin/ANEC-30-e70067-s001.docx" data-ga-action="click_feat_suppl" class="usa-link">ANEC-30-e70067-s001.docx</a><sup> (1.5MB, docx) </sup>
</div></div></section></section><section id="anec70067-sec-0016" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>The authors have nothing to report.</p></section><section id="notes1"><section id="anec70067-ntgp-0001" class="fn-group"><div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="anec70067-note-0001"><p>
<strong>Funding:</strong> This work was supported by Daiichi‐Sankyo Co. Ltd., Chuo‐ku, Tokyo, Japan.</p></div></div></section></section><section id="anec70067-sec-0021"><h2 class="pmc_sec_title">Data Availability Statement</h2>
<p>The deidentified participant data and the study protocol will be shared on a request basis for up to 36 months after the publication of this article. Researchers who make the request should include a methodologically sound proposal on how the data will be used; the proposal may be reviewed by the responsible personnel at DAIICHI SANKYO Co. Ltd., and the data requestors will need to sign a data access agreement. Proposals should be directed to <span>akihiko-ind@umin.ac.jp</span>.</p></section><section id="anec70067-bibl-0001" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="anec70067-bibl-0001_sec2"><ol class="ref-list font-sm">
<li id="anec70067-bib-0001">
<cite>

Atti, V.
, Turagam M. K., Viles‐Gonzalez J. F., and Lakkireddy D.. 2018. “Anticoagulation After Catheter Ablation of Atrial Fibrillation: Is It Time to Discontinue in Select Patient Population?” Journal of Atrial Fibrillation
11: 2092.
</cite> [<a href="https://doi.org/10.4022/jafib.2092" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6533831/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31139286/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Atrial%20Fibrillation&amp;title=Anticoagulation%20After%20Catheter%20Ablation%20of%20Atrial%20Fibrillation:%20Is%20It%20Time%20to%20Discontinue%20in%20Select%20Patient%20Population?&amp;author=V.%20Atti&amp;author=M.%20K.%20Turagam&amp;author=J.%20F.%20Viles%E2%80%90Gonzalez&amp;author=D.%20Lakkireddy&amp;volume=11&amp;publication_year=2018&amp;pages=2092&amp;pmid=31139286&amp;doi=10.4022/jafib.2092&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="anec70067-bib-0002">
<cite>

Gage, B. F.
, Waterman A. D., Shannon W., Boechler M., Rich M. W., and Radford M. J.. 2001. “Validation of Clinical Classification Schemes for Predicting Stroke: Results From the National Registry of Atrial Fibrillation.” JAMA
285: 2864–2870.
</cite> [<a href="https://doi.org/10.1001/jama.285.22.2864" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11401607/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=Validation%20of%20Clinical%20Classification%20Schemes%20for%20Predicting%20Stroke:%20Results%20From%20the%20National%20Registry%20of%20Atrial%20Fibrillation&amp;author=B.%20F.%20Gage&amp;author=A.%20D.%20Waterman&amp;author=W.%20Shannon&amp;author=M.%20Boechler&amp;author=M.%20W.%20Rich&amp;volume=285&amp;publication_year=2001&amp;pages=2864-2870&amp;pmid=11401607&amp;doi=10.1001/jama.285.22.2864&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="anec70067-bib-0003">
<cite>

Hindricks, G.
, Potpara T., Dagres N., et al. 2021. “2020 ESC Guidelines for the Diagnosis and Management of Atrial Fibrillation Developed in Collaboration With the European Association for Cardio‐Thoracic Surgery (EACTS): The Task Force for the Diagnosis and Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Developed With the Special Contribution of the European Heart Rhythm Association (EHRA) of the ESC.” European Heart Journal
42: 373–498.
</cite> [<a href="https://doi.org/10.1093/eurheartj/ehaa612" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32860505/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Heart%20Journal&amp;title=2020%20ESC%20Guidelines%20for%20the%20Diagnosis%20and%20Management%20of%20Atrial%20Fibrillation%20Developed%20in%20Collaboration%20With%20the%20European%20Association%20for%20Cardio%E2%80%90Thoracic%20Surgery%20(EACTS):%20The%20Task%20Force%20for%20the%20Diagnosis%20and%20Management%20of%20Atrial%20Fibrillation%20of%20the%20European%20Society%20of%20Cardiology%20(ESC)%20Developed%20With%20the%20Special%20Contribution%20of%20the%20European%20Heart%20Rhythm%20Association%20(EHRA)%20of%20the%20ESC&amp;author=G.%20Hindricks&amp;author=T.%20Potpara&amp;author=N.%20Dagres&amp;volume=42&amp;publication_year=2021&amp;pages=373-498&amp;pmid=32860505&amp;doi=10.1093/eurheartj/ehaa612&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="anec70067-bib-0004">
<cite>

Kanaoka, K.
, Nishida T., Iwanaga Y., et al. 2024. “Oral Anticoagulation After Atrial Fibrillation Catheter Ablation: Benefits and Risks.” European Heart Journal
7: 522–534.</cite> [<a href="https://doi.org/10.1093/eurheartj/ehad798" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10873714/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38117227/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Heart%20Journal&amp;title=Oral%20Anticoagulation%20After%20Atrial%20Fibrillation%20Catheter%20Ablation:%20Benefits%20and%20Risks&amp;author=K.%20Kanaoka&amp;author=T.%20Nishida&amp;author=Y.%20Iwanaga&amp;volume=7&amp;publication_year=2024&amp;pages=522-534&amp;pmid=38117227&amp;doi=10.1093/eurheartj/ehad798&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="anec70067-bib-0005">
<cite>

Karasoy, D.
, Gislason G. H., Hansen J., et al. 2015. “Oral Anticoagulation Therapy After Radiofrequency Ablation of Atrial Fibrillation and the Risk of Thromboembolism and Serious Bleeding: Long‐Term Follow‐Up in Nationwide Cohort of Denmark.” European Heart Journal
36: 307–314a.
</cite> [<a href="https://doi.org/10.1093/eurheartj/ehu421" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25368205/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Heart%20Journal&amp;title=Oral%20Anticoagulation%20Therapy%20After%20Radiofrequency%20Ablation%20of%20Atrial%20Fibrillation%20and%20the%20Risk%20of%20Thromboembolism%20and%20Serious%20Bleeding:%20Long%E2%80%90Term%20Follow%E2%80%90Up%20in%20Nationwide%20Cohort%20of%20Denmark&amp;author=D.%20Karasoy&amp;author=G.%20H.%20Gislason&amp;author=J.%20Hansen&amp;volume=36&amp;publication_year=2015&amp;pages=307-314a&amp;pmid=25368205&amp;doi=10.1093/eurheartj/ehu421&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="anec70067-bib-0006">
<cite>

Lip, G. Y.
, Nieuwlaat R., Pisters R., Lane D. A., and Crijns H. J.. 2010. “Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor‐Based Approach: The Euro Heart Survey on Atrial Fibrillation.” Chest
137: 263–272.
</cite> [<a href="https://doi.org/10.1378/chest.09-1584" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19762550/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Chest&amp;title=Refining%20Clinical%20Risk%20Stratification%20for%20Predicting%20Stroke%20and%20Thromboembolism%20in%20Atrial%20Fibrillation%20Using%20a%20Novel%20Risk%20Factor%E2%80%90Based%20Approach:%20The%20Euro%20Heart%20Survey%20on%20Atrial%20Fibrillation&amp;author=G.%20Y.%20Lip&amp;author=R.%20Nieuwlaat&amp;author=R.%20Pisters&amp;author=D.%20A.%20Lane&amp;author=H.%20J.%20Crijns&amp;volume=137&amp;publication_year=2010&amp;pages=263-272&amp;pmid=19762550&amp;doi=10.1378/chest.09-1584&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="anec70067-bib-0007">
<cite>

Liu, X.‐H.
, Xu Q., Luo T., Ahang L., and Liu H.‐J.. 2021. “Discontinuation of Oral Anticoagulation Therapy After Successful Atrial Fibrillation Ablation: A Systematic Review and Meta‐Analysis of Prospective Studies.” PLoS One
16: e0253709.
</cite> [<a href="https://doi.org/10.1371/journal.pone.0253709" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8224925/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34166470/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=Discontinuation%20of%20Oral%20Anticoagulation%20Therapy%20After%20Successful%20Atrial%20Fibrillation%20Ablation:%20A%20Systematic%20Review%20and%20Meta%E2%80%90Analysis%20of%20Prospective%20Studies&amp;author=X.%E2%80%90H.%20Liu&amp;author=Q.%20Xu&amp;author=T.%20Luo&amp;author=L.%20Ahang&amp;author=H.%E2%80%90J.%20Liu&amp;volume=16&amp;publication_year=2021&amp;pages=e0253709&amp;pmid=34166470&amp;doi=10.1371/journal.pone.0253709&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="anec70067-bib-0008">
<cite>

Nogami, A.
, Kurita T., Abe H., et al. 2021. “JCS/JHRS 2019 Guideline on Non‐Pharmacotherapy of Cardiac Arrhythmias.” Journal Arrhythm
37: 709–870.</cite> [<a href="https://doi.org/10.1002/joa3.12491" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8339126/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34386109/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20Arrhythm&amp;title=JCS/JHRS%202019%20Guideline%20on%20Non%E2%80%90Pharmacotherapy%20of%20Cardiac%20Arrhythmias&amp;author=A.%20Nogami&amp;author=T.%20Kurita&amp;author=H.%20Abe&amp;volume=37&amp;publication_year=2021&amp;pages=709-870&amp;pmid=34386109&amp;doi=10.1002/joa3.12491&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="anec70067-bib-0009">
<cite>

Nogami, A.
, Soejima K., Morishima I., et al. 2022. “Real‐World Investigation on Anticoagulation Management Before and After Catheter Ablation for Atrial Fibrillation in Japan‐Periprocedural and Long‐Term Outcomes.” Circulation Journal
87: 50–62.
</cite> [<a href="https://doi.org/10.1253/circj.CJ-22-0290" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35989303/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation%20Journal&amp;title=Real%E2%80%90World%20Investigation%20on%20Anticoagulation%20Management%20Before%20and%20After%20Catheter%20Ablation%20for%20Atrial%20Fibrillation%20in%20Japan%E2%80%90Periprocedural%20and%20Long%E2%80%90Term%20Outcomes&amp;author=A.%20Nogami&amp;author=K.%20Soejima&amp;author=I.%20Morishima&amp;volume=87&amp;publication_year=2022&amp;pages=50-62&amp;pmid=35989303&amp;doi=10.1253/circj.CJ-22-0290&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="anec70067-bib-0010">
<cite>

Pisters, R.
, Lane D. A., Nieuwlaat R., de Vos C. B., Crijns H. J., and Lip G. Y.. 2010. “A Novel User‐Friendly Score (HAS‐BLED) to Assess 1‐Year Risk of Major Bleeding in Patients With Atrial Fibrillation: The Euro Heart Survey.” Chest
138: 1093–1100.
</cite> [<a href="https://doi.org/10.1378/chest.10-0134" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20299623/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Chest&amp;title=A%20Novel%20User%E2%80%90Friendly%20Score%20(HAS%E2%80%90BLED)%20to%20Assess%201%E2%80%90Year%20Risk%20of%20Major%20Bleeding%20in%20Patients%20With%20Atrial%20Fibrillation:%20The%20Euro%20Heart%20Survey&amp;author=R.%20Pisters&amp;author=D.%20A.%20Lane&amp;author=R.%20Nieuwlaat&amp;author=C.%20B.%20de%20Vos&amp;author=H.%20J.%20Crijns&amp;volume=138&amp;publication_year=2010&amp;pages=1093-1100&amp;pmid=20299623&amp;doi=10.1378/chest.10-0134&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="anec70067-bib-0011">
<cite>

Schulman, S.
, and Kearon C.. 2005. “Definition of Major Bleeding in Clinical Investigations of Antihemostatic Medicinal Products in Non‐Surgical Patients.” Journal of Thrombosis and Haemostasis
3: 692–694.
</cite> [<a href="https://doi.org/10.1111/j.1538-7836.2005.01204.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15842354/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Thrombosis%20and%20Haemostasis&amp;title=Definition%20of%20Major%20Bleeding%20in%20Clinical%20Investigations%20of%20Antihemostatic%20Medicinal%20Products%20in%20Non%E2%80%90Surgical%20Patients&amp;author=S.%20Schulman&amp;author=C.%20Kearon&amp;volume=3&amp;publication_year=2005&amp;pages=692-694&amp;pmid=15842354&amp;doi=10.1111/j.1538-7836.2005.01204.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="anec70067-bib-0012">
<cite>

Tzeis, S.
, Gerstenfeld E. P., Kalman J., et al. 2024. “2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation.” Europace
26: 1–107.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Europace&amp;title=2024%20European%20Heart%20Rhythm%20Association/Heart%20Rhythm%20Society/Asia%20Pacific%20Heart%20Rhythm%20Society/Latin%20American%20Heart%20Rhythm%20Society%20Expert%20Consensus%20Statement%20on%20Catheter%20and%20Surgical%20Ablation%20of%20Atrial%20Fibrillation&amp;author=S.%20Tzeis&amp;author=E.%20P.%20Gerstenfeld&amp;author=J.%20Kalman&amp;volume=26&amp;publication_year=2024&amp;pages=1-107&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="anec70067-bib-0013">
<cite>

Yang, W. Y.
, Du X., Jiang C., et al. 2020. “The Safety of Discontinuation of Oral Anticoagulation Therapy After Apparently Successful Atrial Fibrillation Ablation: A Report From the Chinese Atrial Fibrillation Registry Study.” Europace
22: 90–99.
</cite> [<a href="https://doi.org/10.1093/europace/euz235" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31909431/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Europace&amp;title=The%20Safety%20of%20Discontinuation%20of%20Oral%20Anticoagulation%20Therapy%20After%20Apparently%20Successful%20Atrial%20Fibrillation%20Ablation:%20A%20Report%20From%20the%20Chinese%20Atrial%20Fibrillation%20Registry%20Study&amp;author=W.%20Y.%20Yang&amp;author=X.%20Du&amp;author=C.%20Jiang&amp;volume=22&amp;publication_year=2020&amp;pages=90-99&amp;pmid=31909431&amp;doi=10.1093/europace/euz235&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ol></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p"><p>
<strong>Appendix S1.</strong> Supporting Information.</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/11966009/bin/ANEC-30-e70067-s001.docx" data-ga-action="click_feat_suppl" class="usa-link">ANEC-30-e70067-s001.docx</a><sup> (1.5MB, docx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The deidentified participant data and the study protocol will be shared on a request basis for up to 36 months after the publication of this article. Researchers who make the request should include a methodologically sound proposal on how the data will be used; the proposal may be reviewed by the responsible personnel at DAIICHI SANKYO Co. Ltd., and the data requestors will need to sign a data access agreement. Proposals should be directed to <span>akihiko-ind@umin.ac.jp</span>.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Annals of Noninvasive Electrocardiology are provided here courtesy of <strong>International Society for Holter and Noninvasive Electrocardiology, Inc. and Wiley Periodicals, Inc.</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1111/anec.70067"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/ANEC-30-e70067.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (606.4 KB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/11966009/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/11966009/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC11966009%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC11966009/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC11966009/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC11966009/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40176712/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC11966009/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40176712/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC11966009/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/11966009/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="tdiWtzoT03Wi5KLEQcq1ewDN2g0isRGsf1CMErx7uX1RlSrLUl73XxABCeD88brq">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Web Policies

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    FOIA

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS Vulnerability Disclosure

    
</a>

                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Help

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Accessibility

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Careers

    
</a>

                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NLM

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NIH

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    USA.gov

    
</a>

                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-370d5dd6.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-917ba005.js"></script>
    
    

    </body>
</html>
